← Leaderboards
Wendy A Henderson
Godx, Inc.
$527,552
Attributed
$1,055,104
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $966.7K · FY2018–19$1M$750K$500K$250K$0
'18
'19
Funding mix
By agency
NIH$1,055,104 · 1
By mechanism
R44$1,055,104 · 1
Top collaborators
- Chang Hee Kim2 shared
Others in their field
Other Emerging Leaders on “Antibiotic Resistance”
- Urs Ochsner · Crestone, Inc.$36,950,837
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$25,064,821
- Bruce Blough · Research Triangle Institute$19,880,022
- Thomas Dick · Rbhs-New Jersey Medical School$15,241,285
- Terry Roemer · Prokaryotics, Inc.$13,917,276
Research focus
Antibiotic ResistanceAntimicrobial ResistanceBedsBenchmarkingCampylobacterCellsCessation Of LifeChildChildhoodClinical ProtocolsClinical ResearchClostridium DifficileCollaborationsCommercializationCompliance BehaviorContractsCooperative Research And Development AgreementCostCryptosporidiumDetectionDevicesDiagnosticDiarrhea3d Print